Build A Bouquet with MSCDA – 2/13/24

We are so excited to announce MSCDA’s inaugural Galentines Day
“Build A Bouquet with MSCDA”
Join us as we fellowship and learn more about Sickle Cell Disease with our new Executive Director Nikia K. Vaughan while having a grand time with our Gal Pal’s.
Build your Valentine bouquet for that someone special or for yourself! 
Bouquets start at $19.99 and a portion of The Bloom Bar will directly benefit Maryland Sickle Cell Disease Association.
So come out in your Pink, Red and Black (optional) for a special Galentines Happy Hour for a good cause! 💗🖤❤
Event Details
Can’t come in person? You can still make a virtual donation. Click here to donate.

Register Today

Fill out my online form.
The Maryland Sickle Cell Disease Association, Inc. (MSCDA) is a 501 (c)(3), tax exempt non profit organization that was incorporated in 2006.

Share this post

Sign up for our email list, or follow us on social media, to stay in-the-know about the Maryland Sickle Cell Disease Association
Scroll to Top

Breaking News

FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

On December 8, 2023, “The U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signaling an innovative advancement in the field of gene therapy."